Original ArticleAssociations of nonrestorative sleep with insomnia, depression, and daytime function
Section snippets
Background
Nonrestorative sleep (NRS) is defined as a subjective experience of unrefreshing sleep [1] or a “feeling that sleep is restless, light, or of poor quality even though the duration may appear normal” [2]. The construct first arose in the 1970s in studies of chronic fatigue and fibromyalgia syndromes [1], [3], [4] and was incorporated as a symptom of insomnia in the DSM III-R of 1987. More recently, studies have begun to examine the prevalence and correlates of NRS [2], [5], [6]. Prevalence
Methods
This analysis is based on a subsample from a larger study that surveyed subjects with an insomnia related health care claim and a randomly selected subsample of individuals who had no insomnia related health care claims. Potential study participants were identified from a health plan in the Midwestern United States consisting of roughly 150,000 members. Subjects were excluded from the study if they had an insurance claim diagnosis for sleep apnea (OSA) or sleep disturbance unspecified. Study
Measures
Respondents were surveyed about the presence and frequency of NRS complaints, depression, insomnia severity, frequency of sleep onset and/or maintenance insomnia, and the use of both prescription and over-the-counter sleep-promoting medications (SPM).
Analysis
The primary analysis sample consisted of 541 subjects who reported NRS (3 or more nights per week) and 717 subjects who reported never experiencing NRS symptoms in the past four weeks and who had data available for all study variables, bringing the total sample size to 1258 respondents. Insomnia symptoms could be reported in either group. The groups differed only in reporting the presence or absence of NRS. Univariate analyses were conducted using Pearson correlation, with a Bonferroni
Aim 1: Insomnia related symptoms and sleep quality in those who report NRS compared with those with no NRS symptoms
Descriptive characteristics of the sample stratified by the presence or absence of NRS are presented in Table 1. Of the NRS group, 49.1% rated their NRS symptoms as severe or very severe while 37.3% and 13.6% rated it as moderate or mild, respectively. The NRS group was slightly younger than the non-NRS group (mean [SD] = 50.8 [14.3] vs. 53.0 [14.8]; p < 0.01). More of the NRS group was female (75.8% vs. 65.7%, p < 0.01) and had current depression (48.4% vs. 24.1%, p < 0.0001). The NRS group had a
Discussion
Our study confirms some previously published findings [2], [8], [9], [19], [20] and also provides new insights into the interactions among depression, NRS, and other insomnia symptoms. Specifically, for some individuals, NRS exists even in the absence of other insomnia symptoms and is associated with increased total sleep duration. In addition, depression is associated with NRS, independent of insomnia severity, and there is a significant interaction between NRS and total sleep duration that
Disclosure of financial interests or relationships
Khaled Sarsour, David Van Brunt and Joseph A Johnston are employees of Eli Lilly and Company.
Dr. Walsh has provided consulting services to the following companies: Pfizer, Sanofi-Aventis, Cephalon, Schering-Plough/Organon, Neurocrine, Takeda America, Actelion, Sepracor, Jazz, Respironics, Transcept, Neurogen, GlaxoSmithKline, Somaxon, Eli Lilly, Evotec, Merck, Kingsdown, Vanda, Ventus, and Somnus.
Research support has been provided to Dr. Walsh’s institution by the following companies: Pfizer,
References (22)
- et al.
Nonrestorative sleep
Sleep Med Rev
(2008) Nocturnal awakenings and comorbid disorders in the American general population
J Psychiatr Res
(2008)- et al.
Global sleep dissatisfaction for the assessment of insomnia severity in the general population of Portugal
Sleep Med
(2005) - et al.
What are the contributing factors for insomnia in the general population?
J Psychosom Res
(2001) - et al.
Sleep problems, comorbid mental disorders, and role functioning in the national comorbidity survey replication
Biol psychiatry
(2006) - et al.
Sleep Disturbance in Fibromyalgia
Sleep Medicine Clinics
(2007) - et al.
Association of insomnia severity and comorbid medical and psychiatric disorders in a health plan-based sample: Insomnia severity and comorbidities
Sleep Med
(2010) - et al.
Validation of the Insomnia Severity Index as an outcome measure for insomnia research
Sleep Med
(2001) - et al.
Poor sleep increases the prospective risk for recurrent events in middle-aged women with coronary disease
The Stockholm Female Coronary Risk Study. J Psychosom Res
(2003) Prevalence and correlates of nonrestorative sleep complaints
Arch Intern Med
(2005)
Fibromyalgia, sleep disorder and chronic fatigue syndrome
Ciba Found Symp
Cited by (41)
Nonrestorative Sleep
2023, Encyclopedia of Sleep and Circadian Rhythms: Volume 1-6, Second EditionChronic fatigue syndrome and sleep
2023, Encyclopedia of Sleep and Circadian Rhythms: Volume 1-6, Second EditionLongitudinal assessment of lifestyle factors associated with nonrestorative sleep in Japan
2023, Sleep MedicineCitation Excerpt :NRS is associated with physical health problems such as obesity, sleep disordered breathing, diabetes mellitus, coronary disease, gastroesophageal reflux disease, and allergic rhinitis [2,6–9]. NRS is also strongly linked with mental health disorders, including anxiety, depression, adjustment disorders, and suicide [10–12]. Thus, NRS is regarded not only as a sleep problem but also as an important general health issue.
Nonrestorative sleep in healthy, young adults without insomnia: associations with executive functioning, fatigue, and pre-sleep arousal
2018, Sleep HealthCitation Excerpt :In addition, perceived daily EF accounted for the association between NRS and pre-sleep arousal, consistent with mediation. Prior studies have found that NRS is associated with reported cognitive difficulties, though the association has often been with single-item concurrent measures.11,32 In the current study, NRS was associated with both perceived daily EF difficulties and performance on a behavioral measure of EF.